Bracco Diagnostics Inc., (BDI) the U.S.-based subsidiary of Bracco Imaging SpA, develops and markets imaging agents for use in X-ray/Computed Tomography (CT), Nuclear Medicine and Magnetic Resonance Imaging (MRI) in the U.S. and Canada. Our leading products represent a significant share of the U.S. diagnostic contrast media market. With headquarters in Monroe Township, NJ, the company is also developing contrast agents for ultrasound procedures.
Committed to Science, Committed to You.TM Our specialized Research and Development (R&D) and technological innovation teams are targeted at developing high-quality processes and products that are safe, effective, and increasingly in tune with the needs of patients and physicians.
Customer Education and Awareness Bracco Diagnostics Inc. (BDI) is committed to providing a wide array of training and educational tools to the diagnostic community centered on topics of practical interest and utility. Ultimately, Bracco Diagnostics Inc. strives to improve patients' lives through the advanced education of imaging professionals. Our educational portfolio is robust and offers cutting-edge training to diagnostic imaging professionals.